References
Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993; 328:1365-1371
Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348:1467–1471.
Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996; 348:1472–1477.
The Council of the European Union, 2003. L 327/34 Official Journal of the European Union 16.12.2003. Council recommendation of 2 December 2003 on cancer screening (2003/878/EC). (consultado 11/08/2018). Disponible en: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32003H0878&qid=1531648578016&from=ES
Jover R, Zapater P, Bujanda L, et al. Endoscopist characteristics that influence the quality of colonoscopy. Endoscopy 2016; 48: 241 - 247.
Kaminski MF, Regula J, Kraszewska E, et al. Quaility Indicators for Colonoscopy and the Risk of Interval Cancer. N Engl J Med 2010; 362: 1795 - 1803.
Barclay R:, Vicari JJ, Doughty AS, et al. Colonoscopic withdrawal Times and Adenoma Detection during Screening Colonoscopy. N Engl J Med 2006; 355: 2533 - 2541.
Corley DA, Jensen CD, Marks AM, et al. Adenoma Detection Rate and Risk of Colorectal Cancer and Death. N Engl J Med 2014; 370: 1298 - 1306.
Zorzi M, Senore C, Turrin A, et al. Appropriateness of endoscopic surveillance recommendations in organised colorectal cancer screening programmes based on the faecal immunochemical test. Gut 2016; 65: 1822 - 1828.
Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial–SCORE. J Natl Cancer Inst. 2011;103:1310–1322.
Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012; 366:2345–57.
Holme O, Loberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. 2014;312:606–15
Atkin W, Wooldrage K, Parkin DM, et al. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. Lancet. 2017;389(10076):1299–311
Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697-706
Løberg M, Kalager M, Holme Ø, et al. Long-Term Colorectal-Cancer Mortality after Adenoma Removal. N Engl J Med 2014;371:799-807.
Mapp TJ, Hardcastle JD, Moss SM, et al. Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening. Br J Surg 1999;86:1286−1291.
Pande R, Froggatt P, Baragwanath P, et al. Survival outcome of patients with screening versus symptomatically detected colorectal cancers. Colorectal Dis 2013;15:74−79.
Gill MD, Bramble MG, Hull MA, et al. Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers. Br J Cancer 2014;111:2076−2081.
Amri R, Bordeianou LG, Sylla P, et al. Impact of screening colonoscopy on outcomes in colon cancer surgery. JAMA Surg 2013;148:747−754.
Shaukat A, Mongin SJ, Geisser MS, et al. Long-Term Mortality after Screening for Colorectal Cancer. N Engl J Med 2013; 369: 1106 - 1114.
Scholefield JH, Moss SM, Mangham CM, et al. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012;61:1036-40
Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-96.
Dominitz JA, Robertson DJ, Ahnen DJ, et al. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design. Am J Gastroenterol 2017; 112: 1736 - 1746.